title: Pulmonary sarcoidosis in a patient with psoriatic arthritis during infliximab therapy.
abstract: The occurrence of sarcoidosis during anti-TNF-alpha therapy has occasionally been published. We report the case of a psoriasis patient who developed pulmonary sarcoidosis during a cycle of therapy with infliximab.
authors.forename: S
authors.initials: S
authors.lastname: Izzi
authors.forename: F
authors.initials: F
authors.lastname: Francesconi
authors.forename: P
authors.initials: P
authors.lastname: Visca
authors.forename: A
authors.initials: A
authors.lastname: Altieri
authors.forename: C
authors.initials: C
authors.lastname: De Mutiis
authors.forename: G
authors.initials: G
authors.lastname: Trevisan
authors.forename: C
authors.initials: C
authors.lastname: Bonifati
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy*; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D008297:Male; D017565:Sarcoidosis, Pulmonary / Q000139:chemically induced*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab